AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Business Of Biotech
Serial Success With Triumvira's Rob Williamson
Mar 11, 2024
Rob Williamson discusses his successful career in biotech startups, focusing on Triumvira's innovative T-cell therapeutics in oncology. He shares insights on cancer therapeutics, dealmaking, and the future of the biotech industry.
31:32
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Rob Williamson transitioned from economics to biotech entrepreneurship, focusing on therapeutic developments and successful clinical phases progression.
- Triumvira's CAR-T technology emphasizes self-regulating mechanisms for solid tumor treatment, ensuring safety, outpatient procedures, and specific antigen targeting.
Deep dives
Transition from Economics to Biotech Entrepreneurship
Robert Williamson, the President and COO of Triumvira, transitioned from studying economics and working in monetary policy to becoming a serial biotech entrepreneur with over 20 startups. Initially aiming for a PhD in economics, Williamson pivoted to business school due to his entrepreneurial instincts. His diverse experiences in consulting and various biotech ventures led him to focus on therapeutic developments, gravitating towards companies advancing through clinical phases.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode